According to the 2006 Sydney Classification criteria for definite APS (2), the IgG/IgM anticardiolipin antibodies (aCL), anti-β2-glycoprotein I antibodies (aβ2GPI), and lupus anticoagulant (LA) were defined as criteria aPLs. This evidence concerns the gene ACLY and autoimmune polyendocrinopathy.